Fangda, Davis Polk and Conyers advised InnoCare Pharma Limited on the deal. InnoCare Pharma Limited executed a successful listing on the Shanghai Stock Exchange’s STAR Market. InnoCare...
InnoCare Pharma Limited’s Listing on Shanghai Stock Exchange
Nanjing Vazyme Biotech’s SSE STAR Market Listing
Fangda Partners advised the sole sponsor and lead underwriter, Huatai United Securities on the deal. Nanjing Vazyme Biotech Co., Ltd. successfully listed on the STAR Market...